Collaboration Between Erasca Inc and Novartis to Advance Clinical Development of Combination Therapy for Solid Tumors and Melanoma
On February 14, 2024, Erasca, Inc. announced its collaboration with Novartis through two clinical trial collaboration and supply agreements. The ...
